Iridium and Lindsey Manufacturing Strike Innovative Utility Partnership
Apr 20, 2017 12:02 pm UTC| Business
MCLEAN, Va., April 20, 2017 -- Iridium Communications (NASDAQ:IRDM) announced today its new partnership with Lindsey Manufacturing, a pioneer in Emergency Restoration Systems (ERS), Transmission Line Monitors (TLM) and...
Fidus Investment Corporation Schedules First Quarter 2017 Earnings Release and Conference Call
Apr 20, 2017 12:02 pm UTC| Business
EVANSTON, Ill., April 20, 2017 -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it will report its first quarter 2017 financial results on Thursday, May 4, 2017 after the...
Fidus Investment Corporation Schedules First Quarter 2017 Earnings Release and Conference Call
Apr 20, 2017 12:02 pm UTC| Business
EVANSTON, Ill., April 20, 2017 -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it will report its first quarter 2017 financial results on Thursday, May 4, 2017 after the...
Fidus Investment Corporation Schedules First Quarter 2017 Earnings Release and Conference Call
Apr 20, 2017 12:02 pm UTC| Business
EVANSTON, Ill., April 20, 2017 -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it will report its first quarter 2017 financial results on Thursday, May 4, 2017 after the...
Chimerix to Host Annual Investor Update on April 27, 2017
Apr 20, 2017 12:02 pm UTC| Business
DURHAM, N.C., April 20, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs, today announced...
Apr 20, 2017 12:02 pm UTC| Business
WATERTOWN, Mass., April 20, 2017 -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Resurgens Orthopaedics, Georgia’s...
Chimerix to Host Annual Investor Update on April 27, 2017
Apr 20, 2017 12:02 pm UTC| Business
DURHAM, N.C., April 20, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs, today announced...